Registered Nurse in Medical Lake, WA Accepting Medicare
5 Registered Nurse nurses found. Showing 1 - 5
 Dr. Pierre John Soffe, M.D. Registered Nurse - Hospice Medicare: Not Enrolled in Medicare Practice Location: 850 Maple Street, Medical Lake, WA 99022 Phone: 509-565-4000 Fax: 509-565-7015 |
 Cindy Lynn Dudley, ARNP Registered Nurse - Psych/Mental Health, Adult Medicare: Medicare Enrolled Practice Location: 2320 S Salnave Rd, Medical Lake, WA 99022 Phone: 509-299-1952 |
Lori D Dixon, R.N. Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 524 S Hallett, Medical Lake, WA 99022 Phone: 509-565-3405 Fax: 509-565-3400 |
Jeremiah Johnson, BSN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 850 Maple St., Medical Lake, WA 99022 Phone: 509-565-4000 |
Ruth Ann Oman, ARNP Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: S 2320 Salnave Rd, Medical Lake, WA 99022 Phone: 509-299-1978 |
News Archive
Also in Global Health News: Asia-Pacific reproductive health; developing country medical waste disposal; draft bill in Uganda; diarrhea deaths in China
"China has called on Asia-Pacific countries to attach greater importance to population and family planning and put more funds into the reproductive health and family planning programmes," the Daily Times reports (10/19).
Reversal of aging in normal human cells
BioTime, Inc., a biotechnology company that develops and markets products in the field of stem cells and regenerative medicine, today announced the publication of a scientific paper titled "Spontaneous Reversal of Developmental Aging in Normal Human Cells Following Transcriptional Reprogramming."
Oxford BioTherapeutics, Menarini Group initiate phase I study of OBT357 (MEN1112) for AML treatment
Oxford BioTherapeutics and Berlin Chemie/ Menarini Biotech/ Menarini Ricerche (belonging to Menarini Group) announce today that they have initiated the first-in-human clinical study of OBT357 (MEN1112), a novel enhanced antibody for the treatment of acute myeloid leukemia (AML).
H1N1 overwhelms hospitals; Sebelius addresses flu vaccine shortage
Hospitals across the country are overwhelmed "as waves of flu patients arrive at their doors, doubling their emergency room volume," USA Today reports. "Just as significant is the effect on intensive care units: A relatively small number of flu patients are requiring intensive care, but some are so ill they will need round-the-clock care for weeks.
Researchers develop first chemical inhibitors for treatment of acute myeloid leukemia
A research team led by Dr. Xiang David Li from the Department of Chemistry at The University of Hong Kong, in collaboration with scientists from Tsinghua University in China, The Rockefeller University, and The University of Texas MD Anderson Cancer Center in the United States, developed the first chemical inhibitors against a novel therapeutic target for treatment of acute myeloid leukemia, a fast-growing cancer of bone marrow and blood cells.
› Verified 6 days ago
Nurse Practitioner
Physician Assistant
Registered Nurse
Licensed Practical Nurse